We close out the year with Tanya Dorff, MD, as she discusses her favorite prostate cancer studies of 2023, including the PSMAfore and CHAARTED trials.
Dr. Dorff is a professor in the Department of Medical Oncology & Therapeutics Research and serves as division chief of the Genitourinary Disease Program at City of Hope.